Pharma Sessions

Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics

September 15, 2022 Season 1 Episode 2
Pharma Sessions
Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics
Show Notes

I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.

We talk about: 

  • Transitioning from clinical practice to med affairs
  • Changes in how other groups in pharma see med affairs
  • The differences between access and adoption (and how to impact both)
  • Advances in patient engagement and much more

A quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.

At one point I reference the MAPS, Future of Medical Affairs report. You can view the whole report here: https://medicalaffairs.org/future-medical-affairs-2030/


Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com